Add Company
Join Now

ProteoMediX AG Revenue and Competitors

License our Company Data API

Schlieren,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ProteoMediX AG's estimated annual revenue is currently $2M per year.(i)
  • ProteoMediX AG's estimated revenue per employee is $155,000

Employee Data

  • ProteoMediX AG has 13 Employees.(i)
  • ProteoMediX AG grew their employee count by -13% last year.

ProteoMediX AG's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is ProteoMediX AG?

Proteomedix enables personalized medicine by developing non-invasive diagnostic tests to detect and assess the prognosis of cancer, as well as to match patients with safer and more effective therapies. The first product is a blood-based test for the early diagnosis of prostate cancer. The main benefit of this test is a significantly higher accuracy compared to today's clinical standard (blood-based PSA test). This reduces unnecessary biopsies and thus results in significant cost savings for the healthcare system and less discomfort for the patient.

keywords:N/A

N/A

Total Funding

13

Number of Employees

$2M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ProteoMediX AG News

2022-04-17 - Digital Pathology Market Study Offering Insights on Latest ...

... Market Study Offering Insights on Latest Advancements, Trends and Analysis to 2029 |Hamamatsu Photonics, Apollo Pacs, Definiens AG.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M150%N/A
#2
$2.8M284%N/A
#3
$5M3210%N/A
#4
$3.9M34N/AN/A
#5
$5.4M35-8%N/A